Visible Genomics Company
Visible Genomics provides a clinically validated age-related macular degeneration (AMD) risk assessment. The company's comprehensive risk assessment provide advanced awareness of disease risk which will empower the patient and healthcare professional to make informed clinical and lifestyle decisions together, help slow or prevent disease, and provide greater access to more patients through affordable, easy, and understandable genetic risk testing.
Technology:
P4 Medicine
Industry:
Asset Management, Biotechnology, Health Care
Headquarters:
Hinsdale, Illinois, United States
Founded Date:
1-1
Employees Number:
1-10
Funding Status:
Seed
Total Funding:
$1M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Seed
Register and Claim Ownership